Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 335

Similar articles for PubMed (Select 7894471)

1.

Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid.

Swaab DF, Raadsheer FC, Endert E, Hofman MA, Kamphorst W, Ravid R.

J Neuroendocrinol. 1994 Dec;6(6):681-7.

PMID:
7894471
2.

Can Alzheimer patients receive information without using it?

Størmer FC.

Med Hypotheses. 2015 Apr 20. pii: S0306-9877(15)00160-7. doi: 10.1016/j.mehy.2015.04.017. [Epub ahead of print] No abstract available.

PMID:
25913540
3.

The Alzheimer conundrum: Entanglements of dementia and aging.

Vardy Y.

Glob Public Health. 2015 Jan;10(1):132-133. Epub 2014 Nov 6. No abstract available.

PMID:
25373454
4.

Changes in oxidative damage, inflammation and [NAD(H)] with age in cerebrospinal fluid.

Guest J, Grant R, Mori TA, Croft KD.

PLoS One. 2014 Jan 14;9(1):e85335. doi: 10.1371/journal.pone.0085335. eCollection 2014.

5.

Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease.

Semba RD, Moghekar AR, Hu J, Sun K, Turner R, Ferrucci L, O'Brien R.

Neurosci Lett. 2014 Jan 13;558:37-40. doi: 10.1016/j.neulet.2013.10.058. Epub 2013 Nov 7.

6.

Metabolite profiling of Alzheimer's disease cerebrospinal fluid.

Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, Hampel H, Kastler J, Senn H.

PLoS One. 2012;7(2):e31501. doi: 10.1371/journal.pone.0031501. Epub 2012 Feb 16.

7.

Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls.

Llano DA, Li J, Waring JF, Ellis T, Devanarayan V, Witte DG, Lenz RA.

Alzheimer Dis Assoc Disord. 2012 Oct-Dec;26(4):322-8. doi: 10.1097/WAD.0b013e31823b2728.

PMID:
22089638
8.

Postmortem serotonin levels in cerebrospinal and pericardial fluids with regard to the cause of death in medicolegal autopsy.

Quan L, Ishikawa T, Hara J, Michiue T, Chen JH, Wang Q, Zhu BL, Maeda H.

Leg Med (Tokyo). 2011 Mar;13(2):75-8. doi: 10.1016/j.legalmed.2010.11.003. Epub 2010 Dec 24.

PMID:
21185763
9.

PRESENILE dementia.

[No authors listed]

Med J Aust. 1946 Mar 2;1:309. No abstract available.

PMID:
21066449
10.

[Not available].

SUPPIGER J.

Schweiz Arch Neurol Psychiatr. 1946;56(2):285-302. Undetermined Language. No abstract available.

PMID:
21019933
11.

CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease.

Motawaj M, Peoc'h K, Callebert J, Arrang JM.

J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.

PMID:
20858978
12.

HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease.

Gil-Bea FJ, Aisa B, Solomon A, Solas M, del Carmen Mugueta M, Winblad B, Kivipelto M, Cedazo-Mínguez A, Ramírez MJ.

J Alzheimers Dis. 2010;22(3):829-38. doi: 10.3233/JAD-2010-100663.

PMID:
20858975
13.

Attenuated antiaggregation effects of magnetite nanoparticles in cerebrospinal fluid of people with Alzheimer's disease.

Gažová Z, Antošová A, Krištofiková Z, Bartoš A, Ríčný J, Cechová L, Klaschka J, Rípová D.

Mol Biosyst. 2010 Nov;6(11):2200-5. doi: 10.1039/c003498c. Epub 2010 Aug 19.

PMID:
20721410
14.

Effects of age on cerebrospinal fluid oxytocin levels in free-ranging adult female and infant rhesus macaques.

Parker KJ, Hoffman CL, Hyde SA, Cummings CS, Maestripieri D.

Behav Neurosci. 2010 Jun;124(3):428-33. doi: 10.1037/a0019576.

15.

[Not Available].

MUTRUX S.

Monatsschr Psychiatr Neurol. 1947;113(2):100-17. Undetermined Language. No abstract available.

PMID:
20295315
16.

Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls.

Pearson A, de Vries A, Middleton SD, Gillies F, White TO, Armstrong IR, Andrew R, Seckl JR, MacLullich AM.

BMC Res Notes. 2010 Feb 8;3:33. doi: 10.1186/1756-0500-3-33.

17.

Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's disease.

Isobe C, Abe T, Terayama Y.

Neurodegener Dis. 2009;6(5-6):252-7. doi: 10.1159/000262443. Epub 2009 Nov 26.

18.

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.

PMID:
19273758
19.

Effect of cortisol levels on working memory performance in elderly subjects with Alzheimer's disease.

Souza-Talarico JN, Caramelli P, Nitrini R, Chaves EC.

Arq Neuropsiquiatr. 2008 Sep;66(3B):619-24.

20.

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Laske C, Stransky E, Fritsche A, Eschweiler GW, Leyhe T.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):80-5. doi: 10.1007/s00406-008-0838-3. Epub 2008 Sep 19.

PMID:
18806919
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk